Medical research

1010 WINS Newsroom
May 25, 2020 - 8:35 pm
CANBERRA, Australia (AP) — A U.S. biotechnology company began injecting a coronavirus vaccine candidate into people in Australia on Tuesday with hopes of releasing a proven vaccine this year. Novavax will inject 131 volunteers in the first phase of the trial testing the safety of the vaccine and...
Read More
FILE - This Tuesday, April 7, 2020 file photo shows a bottle of hydroxychloroquine tablets in Texas City, Texas. The World Health Organization said Monday May 25, 2020, that it will temporarily drop hydroxychloroquine from its global study into experimental COVID-19 treatments because its experts need to review all available evidence. (AP Photo/David J. Phillip, File)
1010 WINS Newsroom
May 25, 2020 - 1:46 pm
GENEVA (AP) — The World Health Organization said Monday that it will temporarily drop hydroxychloroquine — the anti-malarial drug U.S. President Trump says he is taking — from its global study into experimental COVID-19 treatments, saying that its experts need to review all available evidence to...
Read More
1010 WINS Newsroom
May 23, 2020 - 2:56 am
UNITED NATIONS (AP) — The U.N. disarmament chief warned Friday that cyber crime is on the rise, with a 600% increase in malicious emails during the COVID-19 pandemic. Izumi Nakamitsu told an informal meeting of the U.N. Security Council that the coronavirus crisis is moving the world toward...
Read More
A health worker checks a computer screen at the COVID-19 test department of the Broussais Hospital in Paris, Monday May 11, 2020. French President Emmanuel Macron has repeatedly pledged the country would be able to test up to 700,000 people per week as key to the re-opening process, but so far the number of people tested is much lower and the effective capacities in the country remain vague. (Alain Jocard, Pool via AP)
1010 WINS Newsroom
May 23, 2020 - 12:42 am
The Latest on the coronavirus pandemic. The new coronavirus causes mild or moderate symptoms for most people. For some, especially older adults and people with existing health problems, it can cause more severe illness or death. TOP OF THE HOUR: —UN warns cybercrime on rise during pandemic. —South...
Read More
FILE - In this Tuesday, May 19, 2020 file photo, a chemist holds a pack of hydroxychloroquine tablets in Mumbai, India. A Friday, May 22, 2029 report in the journal Lancet shows malaria drugs pushed by U.S. President Donald Trump as treatments for the coronavirus not only did not help but were tied to a greater risk of death and heart rhythm problems in a study of nearly 100,000 patients around the world. (AP Photo/Rafiq Maqbool)
1010 WINS Newsroom
May 22, 2020 - 7:04 pm
Malaria drugs pushed by President Donald Trump as treatments for the coronavirus did not help and were tied to a greater risk of death and heart rhythm problems in a new study of nearly 100,000 patients around the world. Friday’s report in the journal Lancet is not a rigorous test of...
Read More
1010 WINS Newsroom
May 21, 2020 - 3:23 am
GENEVA (AP) — The World Health Organization, which has come under repeated fire from U.S. President Donald Trump, says the science is still unclear on an old malaria drug he's taking to try to defend against the novel coronavirus. It says it recommends the drug's use for COVID-19 only in controlled...
Read More
President Donald Trump speaks during an event on the food supply chain amid the coronavirus pandemic, in the Roosevelt Room of the White House, Tuesday, May 19, 2020, in Washington. (AP Photo/Evan Vucci)
1010 WINS Newsroom
May 20, 2020 - 6:36 am
WASHINGTON (AP) — President Donald Trump emphatically defended himself against criticism from medical experts that his announced use of a malaria drug against the coronavirus could spark wide misuse by Americans of the unproven treatment with potentially fatal side effects. Trump's revelation a day...
Read More
A chemist displays hydroxychloroquine tablets in Mumbai, India, Tuesday, May 19, 2020. President Donald Trump’s declaration that he was taking the antimalarial drug of dubious effectiveness to help fend off the coronavirus will be welcomed in India. Trump's previous endorsement of hydroxychloroquine catalyzed a tremendous shift in the South Asian country, spurring the world’s largest producer of the drug to make much more of it, prescribe it for front-line health workers treating cases of the coronavirus and deploy it as a diplomatic tool, despite mounting evidence against using the drug for COVID-19. (AP Photo/Rafiq Maqbool)
1010 WINS Newsroom
May 19, 2020 - 8:50 pm
NEW DELHI (AP) — President Donald Trump’s declaration that he was taking a malaria drug of dubious effectiveness to help fend off the coronavirus will likely be welcomed in India. Trump's previous endorsement of hydroxychloroquine catalyzed a tremendous shift in the South Asian country, spurring...
Read More
Veterans Affairs Secretary Robert Wilkie speaks about protecting seniors, in the East Room of the White House, Thursday, April 30, 2020, in Washington. (AP Photo/Alex Brandon)
1010 WINS Newsroom
May 16, 2020 - 12:14 am
WASHINGTON (AP) — Facing growing criticism, the Department of Veterans Affairs said Friday that it will not halt use of an unproven malaria drug on veterans with COVID-19 but that fewer of its patients are now taking it. In responses provided to Congress and obtained by The Associated Press, the VA...
Read More
FILE - In this March 16, 2020 file photo, a patient receives a shot in the first-stage safety study clinical trial of a potential vaccine for COVID-19, the disease caused by the new coronavirus, at the Kaiser Permanente Washington Health Research Institute in Seattle. In a press briefing on Thursday May 14, 2020, the European Medicines Agency predicted that there could be licensed drugs to treat the new coronavirus in the next few months and that a vaccine might even be approved in early 2021, in a “best-case scenario.” (AP Photo/Ted S. Warren, File)
1010 WINS Newsroom
May 14, 2020 - 7:19 am
LONDON (AP) — The European Medicines Agency predicted that there could be licensed drugs to treat the new coronavirus in the next few months and that a vaccine might even be approved in early 2021, in a “best-case scenario.” Dr. Marco Cavaleri, who heads the European regulator’s vaccines department...
Read More

Pages